Filing Flows › Teleflex (TFX) › Guidance & outlook
Teleflex (TFX) guidance and outlook
Teleflex (TFX) raised some and lowered other parts of its guidance on Nov 5, 2026: EPS $7.50–$7.75 for FY2026; Revenue +13.2% to +14.2% for FY2026; EPS $2.84–$3.09 for FY2026; Revenue +10% for FY2025. Teleflex's 10-Q filed Nov 5, 2026 makes 17 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | +3.5% to +4.5% | reaffirmed |
| EPS | FY2026 | $7.50–$7.75 | raised |
| Revenue | FY2026 | +13.2% to +14.2% | lowered |
| EPS | FY2026 | $2.84–$3.09 | raised |
| Revenue | FY2025 | +10% | reaffirmed |
| Revenue | FY2026 | +10% | reaffirmed |
| EPS | FY2025 | $2.84 | raised |
| EPS | FY2025 | $7.50 | raised |
From the earnings release filed Nov 5, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 5, 2026
- Upon closing, we expect to receive gross cash proceeds of approximately $530 million, subject to certain working capital and other customary adjustments and transaction costs.
- For this transaction, we have also negotiated transition services agreements and other arrangements intended to govern ongoing activities between Teleflex and the buyer following the closing date of the transaction, including interim operating model arrangements and manufacturing and supply services.
- Although the material terms of these agreements have been substantially determined, they remain subject to finalization and execution, which we expect to complete at closing.
- We anticipate submitting additional refund requests during the fourth quarter of 2026 under the final phase of the IEEPA tariff refund process.
- Research and development expenses for the three months ended September 30, 2026 decreased $1.3 million compared to the prior year period, which was primarily attributable to lower European Union Medical Device Regulation related costs, partially offset by higher project spend within our Interventional product portfolio.
- Research and development expenses for the nine months ended September 30, 2026 increased $36.4 million compared to the prior year period, which was due to higher project spend within our Interventional product portfolio primarily associated with the acquired VI Business.
- We estimate that we will incur aggregate pre-tax restructuring and restructuring related charges in connection with the plan of $9 million to $12 million.
- We expect to achieve annual pre-tax savings in connection with the 2023 Footprint realignment plan of $2 million to $4 million once the plan is fully implemented.
- We estimate that we will incur aggregate pre-tax restructuring and restructuring related charges in connection with the VI Business integration plan of $36 million to $44 million.
- We expect all the restructuring and restructuring related charges will result in future cash outlays.
- We expect to achieve annual pre-tax savings of $24 million to $30 million in connection with the VI Business integration plan once it is fully implemented.
- During the first quarter of 2026, in connection with the Strategic Divestitures, we initiated a multi-year restructuring plan intended to align our global organizational structure and supply chain infrastructure amongst our remaining businesses (the "Strategic Divestitures restructuring plan").
Teleflex's latest quarter
Teleflex, Q3 2026: revenue $568M (+0.1% year over year), operating margin 18.6%, net earnings $927M, operating cash flow $96.3M. The chart follows the revenue to costs, profit and cash.
Questions
Did Teleflex raise or lower its guidance?
Teleflex (TFX) raised some and lowered other parts of its guidance on Nov 5, 2026: EPS $7.50–$7.75 for FY2026; Revenue +13.2% to +14.2% for FY2026; EPS $2.84–$3.09 for FY2026; Revenue +10% for FY2025.
What does Teleflex expect?
Upon closing, we expect to receive gross cash proceeds of approximately $530 million, subject to certain working capital and other customary adjustments and transaction costs. For this transaction, we have also negotiated transition services agreements and other arrangements intended to govern ongoing activities between Teleflex and the buyer following the closing date of the transaction, including interim operating model arrangements and manufacturing and supply services. Although the material terms of these agreements have been substantially determined, they remain subject to finalization an
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.